Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Sinoregen Medical Materials is a high-tech biotechnology company specializing in the research, development, and manufacturing of advanced regenerative medical biomaterials. The company focuses on tissue engineering solutions, particularly in the fields of surgical hemostasis, bone repair, and advanced wound care. Its core product portfolio includes absorbable hemostatic gauze, artificial bone graft materials, and collagen-based dressings designed to facilitate natural tissue regeneration. Sinoregen leverages proprietary technologies in processing natural polymers such as chitosan and collagen to create biocompatible scaffolds for clinical use. Headquartered in Guangzhou, China, the company operates GMP-certified facilities and serves a wide range of medical specialties including general surgery, orthopedics, and dentistry. Sinoregen is recognized for its innovation in absorbable materials and holds numerous patents within the Chinese medical device sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Sinoregen Medical Materials.